ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

Congress Approves More Favorable Terms for Office-Administered Drugs

August 8, 1997

Device Shortens Time To Make T Cells For Immunotherapy

March 27, 2009

Duke Vice Dean Cuffe Promises Complete, Independent Probe Of Work By Potti, Nevins.

July 30, 2010

New Criteria For Comprehensive center Status finalized

November 17, 1989

Ohio Legislature Gives $1 Million To Cancer Control

August 19, 1983

In Brief: fraud By Trainee Leads Collins To Retract Five Paper; Weinstein Retires At Columbia

November 1, 1996